Results 121 to 130 of about 11,332,305 (264)

Review of Graphene Liquid Cell (In Situ TEM) for Battery Materials

EcoEnergy, EarlyView.
This review outlines the principles, fabrication, and applications of graphene liquid‐cell TEM in battery research. GLC‐TEM enables real‐time, high‐resolution imaging while minimizing beam damage. Advances such as flow‐type designs, MEMS integration, and AI‐based analysis address current limitations, offering new opportunities for studying battery ...
Pendo Bigambo, Jacob Choe, Jeongmin Kim, Junpyo Hur, Jaeeun Joo, Sanghyeon Ji, Jun Young Cheong, Jong Min Yuk   +7 more
wiley   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Anti-amyloid-β monoclonal antibody for Alzheimer's disease: value, clinical practice and challenges

Chinese Journal of Contemporary Neurology and Neurosurgery
The success of anti-amyloid-β (Aβ) monoclonal antibody has marked the beginning of the disease-modifying therapy (DMT) era for Alzheimer's disease (AD). As these agents are increasingly adopted in clinical practice, the focus of management has gradually ...
WANG Gang, GENG Jie-li
doaj   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study [PDF]

, 2017
BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer's disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to ...
Ingala, S, Sanchez, E, Martens, RM, van Schijndel, RA, Machado, VB, Bechten, A, Purcell, D, de Jong, MC, Barkhof, F, Wattjes, MP, Brashear, RH, Arrighi, MH   +11 more
core   +1 more source

ED care and Amyloid‐Related Imaging Abnormalities ‐ Impact and Future research [PDF]

Alzheimers Dement
AbstractWith the approval of disease modifying treatments for Alzheimer’s Disease, the practice of dementia care and treatment has changed. Amyloid related imaging changes, are the most common adverse effects of these types of drugs. There is limited guidance across multiple specialties on how to recognize and manage these changes in a dementia patient
Aggarwal N, Carpenter C.
europepmc   +2 more sources

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease.

JAMA Neurol
ImportanceData from 2 phase 3 studies of gantenerumab, GRADUATE I/II, and their open-label extensions represent a resource to further characterize amyloid-related imaging abnormalities (ARIA), including long-term sequelae.ObjectivesTo describe the characteristics of ARIA and risk factors and clinical consequences of ARIA-edema (ARIA-E).Design, Setting,
Salloway S, Wojtowicz J, Voyle N, Lane CA, Klein G, Lyons M, Rossomanno S, Mazzo F, Bullain S, Barkhof F, Bittner T, Schneider A, Grundman M, Aldea R, Boada M, Smith J, Doody R.   +16 more
europepmc   +5 more sources

The Association Between Retinal Vasculopathy and Retinal Amyloid-Beta Accumulation

, 2020
Patients with Alzheimer\u27s disease (AD)-related cognitive disorders exhibit retinal and choroidal vascular abnormalities and intraretinal accumulation of Aβ plaque. Modern retinal imaging modalities to quantify retinal vasculopathy and amyloid-beta (Aβ)
Oana M. Dumitrascu; Maziyar Khansari; Yonggang Shi; Julia Sheyn; Patrick Lyden; Steven Verdooner; Keith Black; Yosef Koronyo; Maya Koronyo-Hamaoui
core  

Does age influence diagnostic outcomes in an adult cohort referred to a first‐seizure clinic?

Epilepsia, EarlyView.
Abstract Objective The aging Danish population is associated with increasing morbidity and healthcare utilization. This study examines age‐related differences in resource utilization and diagnostic outcomes between older (65–95 years) and younger adults (18–64 years) evaluated for suspected epilepsy, including clinical management, diagnostic yield, and
Anne Line Lund Birkmose, Corinna Lackmann, Lars Hageman Pinborg, Kimmo Jensen   +3 more
wiley   +1 more source

A regional framework for the detection and management of ARIA with anti-amyloid therapies in early Alzheimer’s disease in Asia

The Journal of Prevention of Alzheimer's Disease
Alzheimer’s disease (AD) is a growing public health concern in Asia, with an increasing prevalence driven by demographic shifts and rising life expectancy.
So Young Moon, Ta-Fu Chen, Bo-Ching Lee, Won Jin Moon, Nagaendran Kandiah, Sumeet Kumar, Young Ho Park, Kaori Inaba, Amitabh Dash   +8 more
doaj   +1 more source